Redeye: Careium Q1'22 - One-Off Costs Hurting Bottom Line
Redeye was taken by surprise by the strong sales figure in the quarter but also notes continuing struggles on the margin side. We believe that the turnaround in the UK will take a few more quarters and that it will hurt the profitability in the meantime.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/